New Yorkers need access to biomarker testing

 “We have the opportunity to reaffirm New York’s position as a nationwide leader in the treatment of disease and prioritization of medical innovation.”

NewYorkBIO’s CEO Jennifer Hawks Bland recently published a letter in The Buffalo News, calling on Governor Hochul to sign the crucial Senate Bill 1196a/Assembly Bill 1673a into law. Read more about why NewYorkBIO is seeking to ensure access to biomarker testing to advance overall health outcomes:

Savings Partners